A cell therapy for solid tumors using peripheral blood-derived TIL-like cells with genetic modifications to enhance receptor and amplification factors, addressing tumor heterogeneity, microenvironment, and cell expansion challenges.

A semi-compatible neoantigen T cell therapy for immune system diseases, showing near-curative effects in T cell lymphoma, potentially a groundbreaking treatment for autoimmune diseases.